DISTRIBUTION OF MULTI DRUG AND EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING Escherichia coli isolated from laying hens and poultry farmers in AFRICA 2010 -2023 DATA CHALLENGE

Global public health is increasingly under risk from antimicrobial resistance (AMR). Treatments become unsuccessful when bacteria, viruses, fungus, or parasites learn to withstand the medications meant to eradicate them. Antibiotic abuse and usage hasten this resistance, resulting in longer hospital stays, higher death rates, and rising medical expenses. This research focuses on the distribution of multi drug and extended spectrum beta-lactamase producing Escherichia coli isolated from laying hens and poultry farmers in AFRICA 2010 -2023 Data Challenge.

Enhancing safe food through knowledge of resistance and dissemination patterns is one of the main goals of this research. Poultry farmers and other stakeholders will be able to better customize antibiotic treatments by knowing the frequency of mediation of multidrug resistance genes. In addition to decreasing the chance of treatment failure, this also expedites recovery and lowers complications. Customers gain from more accurate and scientifically supported food products, which guarantee they are given the right food.

Antimicrobial resistance is a serious global issue that requires concerted efforts across healthcare, public policy, and scientific research. The goal of this research is to improve patient care, assist stewardship initiatives, guide public health initiatives, and fortify health systems by examining the causes of resistance. Antibiotics will continue to be an effective means of combating illnesses for many generations to come if AMR is recognized and addressed.